Advisory Services Network’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-320
Closed -$2K 3531
2021
Q2
$2K Buy
+320
New +$1.88K ﹤0.01% 3394
2021
Q1
Sell
-320
Closed -$2K 3197
2020
Q4
$2K Hold
320
﹤0.01% 3080
2020
Q3
$2K Buy
+320
New +$1.92K ﹤0.01% 3237
2020
Q2
Sell
-5,600
Closed -$36K 2961
2020
Q1
$36K Sell
5,600
-9,250
-62% -$74.2K ﹤0.01% 1550
2019
Q4
$155K Buy
+14,850
New +$108K 0.01% 982
2018
Q4
Sell
-300
Closed -$9K 2720
2018
Q3
$9K Buy
+300
New +$11.6K ﹤0.01% 1869

Other funds holding CLVS

Advisory Services Network's CLVS Position: Q3 2021 in Review

Advisory Services Network sold out of Clovis Oncology, Inc. (CLVS) in Q3 2021, closing a stake of 320 shares — an estimated $2K sold.

Advisory Services Network first reported a position in CLVS in Q3 2018 and held it in 6 quarters. The position peaked at $155K in Q4 2019. 157 funds tracked by Wall St. Rank hold CLVS as of Q3 2021.

  • Advisory Services Network reported no remaining Clovis Oncology, Inc. position as of Q3 2021 after selling out during the quarter.
  • Advisory Services Network sold 320 Clovis Oncology, Inc. shares in Q3 2021, an estimated $2K.
  • Advisory Services Network first reported a position in Clovis Oncology, Inc. in Q3 2018 and held it in 6 quarters.
  • Advisory Services Network's Clovis Oncology, Inc. position peaked at $155K in Q4 2019.
  • 157 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.